Outcome measures in acute gout: a systematic literature review (Q38170977)

30 August 2017

Outcome measures in acute gout: a systematic literature review (English)

1 reference

30 August 2017

1

Nicola Dalbeth

1 reference

30 August 2017

Jasvinder A Singh

6

0 references

William J Taylor

8

object named as

William J Taylor

1 reference

30 August 2017

3

Rebecca Grainger

1 reference

30 August 2017

Cathy S Zhong

2

1 reference

30 August 2017

Dinesh Khanna

4

1 reference

30 August 2017

Puja P Khanna

5

1 reference

30 August 2017

Fiona M McQueen

7

1 reference

30 August 2017

language of work or name

English

0 references

publication date

15 December 2013

1 reference

The Journal of Rheumatology

30 August 2017

1 reference

30 August 2017

41

1 reference

30 August 2017

3

1 reference

30 August 2017

558-568

1 reference

Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials

30 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Serum urate in chronic gout - will it be the first validated soluble biomarker in rheumatology?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Patient-reported outcomes in chronic gout: a report from OMERACT 10

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Progress in measurement instruments for acute and chronic gout studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Outcome evaluations in gout

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Gout-associated uric acid crystals activate the NALP3 inflammasome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Outcome measures for acute and chronic gout.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Local ice therapy during bouts of acute gouty arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Evaluation of tenoxicam in rheumatology--clinical trial results in Argentina and Brazil

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Does colchicine work? The results of the first controlled study in acute gout.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Intravenous indoprofen for prompt relief of acute gout: a regimen-finding study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Piroxicam in the Treatment of Acute Gout: A Multicentre Open Study in General Practice

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Randomized and controlled clinical study of modified prescriptions of Simiao Pill in the treatment of acute gouty arthritis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Treatment of Acute Gouty Arthritis with Proquazone and Indomethacin: A Comparative, Double-blind Trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

The anti-inflammatory and anti-hyperuricemic effects of Chinese herbal formula danggui-nian-tong-tang on acute gouty arthritis: a comparative study with indomethacin and allopurinol

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

The Treatment of Acute Gout with Naproxen

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Outcome domains for studies of acute and chronic gout

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Comparative study on treatment of acute gouty arthritis by electroacupuncture with different frequency.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4217650

Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study

31 August 2018

1 reference

12 December 2020

Clinical experience with isoxicam in patients with acute gout

1 reference

12 December 2020

Fentiazac in acute gouty arthritis

1 reference

12 December 2020

Piroxicam in treatment of acute gout high dose versus low dose

1 reference

12 December 2020

Flurbiprofen in the treatment of acute gout. A comparison with indomethacin

1 reference

12 December 2020

Clinical experiences with the intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effect

1 reference

12 December 2020

Use of tenoxicam in patients with acute gouty arthritis

1 reference

12 December 2020

Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine

1 reference

12 December 2020

The OMERACT filter for Outcome Measures in Rheumatology

1 reference

12 December 2020

Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide

1 reference

12 December 2020

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout

1 reference

12 December 2020

Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout

1 reference

12 December 2020

A Comparison of Phenylbutazone and Flufenamic Acid in the Treatment of Acute Gout

1 reference

12 December 2020

Indoprofen for acute gouty arthritis

1 reference

12 December 2020

Indoprofen in rheumatic patients with acute episodes: a multicentre trial

1 reference

12 December 2020

Use of piroxicam in the treatment of acute gout

1 reference

12 December 2020

Identifiers

DOI

10.3899/JRHEUM.131244

1 reference

30 August 2017

1 reference

30 August 2017

PubMed publication ID

24334652

1 reference